glp-1 fda approval Lilly is now pharma's top revenue company. It just got for an oral GLP-1, but Wall Street isn't celebrating 💊New GLP-1 pill gets FDA

RGDS TanTrap Rated 5 out of 5 kevinacton03 (verified owner) Great product works really well people are always asking me if I have been on holiday, quick delivery nicely packaged

However, early prescription data have been modest versus Novo's oral Wegovy, and the FDA has also asked Lilly for additional post-marketing safety data related to potential liver injury

There is currently no definitive evidence establishing that one GLP-1 receptor agonist is superior to another specifically for anti-inflammatory effects

JJotSoF, Agriculture 93:7817

With the patent on the semaglutide molecule having expired in India in March, the market has close to 50 different brands of semaglutide generics vying for attention at competitive pricing